Okairos initiates Phase I/II clinical trial for potential first-in-class hepatitis C vaccine
 |
14.03.2012
Okairos today announced the initiation of a Phase I/II clinical trial evaluating its vaccine against the hepatitis C virus (HCV).
 | 21 kB |
|
14.03.2012
Okairos today announced the initiation of a Phase I/II clinical trial evaluating its vaccine against the hepatitis C virus (HCV).
| 21 kB |